Skin and nail changes in children with sickle cell anemia receiving hydroxyurea therapy

被引：33

作者：

O'Branski, EE

Ware, RE

Prose, NS

Kinney, TR

机构：

[1] Duke Univ, Med Ctr, Dept Pediat, Div Hematol Oncol, Durham, NC 27710 USA

[2] Duke Univ, Med Ctr, Pediat Sickle Cell Program, Durham, NC 27710 USA

[3] Duke Univ, Med Ctr, Dept Med, Div Dermatol, Durham, NC 27710 USA

来源：

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2001年 / 44卷 / 05期

基金：

美国国家卫生研究院;

关键词：

D O I：

10.1067/mjd.2001.113471

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

Skin and nail changes from long-term hydroxyurea therapy are reported in adults. Skin and nail changes, including nail hyperpigmentation, longitudinal bands, and hyperpigmentation of the palms and other skin surfaces, developed in 7 children with sickle cell anemia after 6 to 16 weeks of hydroxyurea therapy. Cutaneous and nail changes may occur in children receiving hydroxyurea.

引用

页码：859 / 861

页数：3

共 13 条

[1]

AdamsGraves P, 1996, NEW ENGL J MED, V334, P333

[2] EFFECTS OF HYDROXYUREA THERAPY ON NORMAL SKIN - A CASE-REPORT [J].

BURNS, DA ;

SARKANY, I ;

GAYLARDE, P .

CLINICAL AND EXPERIMENTAL DERMATOLOGY, 1980, 5 (04) :447-449

[3] EFFECT OF HYDROXYUREA ON THE FREQUENCY OF PAINFUL CRISES IN SICKLE-CELL-ANEMIA [J].

CHARACHE, S ;

TERRIN, ML ;

MOORE, RD ;

DOVER, GJ ;

BARTON, FB ;

ECKERT, SV ;

MCMAHON, RP ;

BONDS, DR ;

ORRINGER, E ;

JONES, S ;

STRAYHORN, D ;

ROSSE, W ;

PHILLIPS, G ;

PEACE, D ;

JOHNSONTELFAIR, A ;

MILNER, P ;

KUTLAR, A ;

TRACY, A ;

BALLAS, SK ;

ALLEN, GE ;

MOSHANG, J ;

SCOTT, B ;

STEINBERG, M ;

ANDERSON, A ;

SABAHI, V ;

PEGELOW, C ;

TEMPLE, D ;

CASE, E ;

HARRELL, R ;

CHILDERIE, S ;

EMBURY, S ;

SCHMIDT, B ;

DAVIES, D ;

KOSHY, M ;

TALISCHYZAHED, N ;

DORN, L ;

PENDARVIS, G ;

MCGEE, M ;

TELFER, M ;

DAVIS, A ;

CASTRO, O ;

FINKE, H ;

PERLIN, E ;

SITEMAN, J ;

GASCON, P ;

DIPAOLO, P ;

GARGIULO, S ;

ECKMAN, J ;

BAILEY, JH ;

PLATT, A .

NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (20) :1317-1322

[4] Hydroxyurea dermopathy: A unique lichenoid eruption complicating long-term therapy with hydroxyurea [J].

Daoud, MS ;

Gibson, LE ;

Pittelkow, MR .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1997, 36 (02) :178-182

[5]

DELMASMARSALET B, 1995, NOUV REV FR HEMATOL, V37, P205

[6] Three-year follow-up of hydroxyurea treatment in severely ill children with sickle cell disease [J].

deMontalembert, M ;

Belloy, M ;

Bernaudin, F ;

Gouraud, F ;

Capdeville, R ;

Mardini, R ;

Philippe, N ;

Jais, JP ;

Bardakdjian, J ;

Ducrocq, R ;

MaierRedelsperger, M ;

Elion, J ;

Labie, D ;

Girot, R .

JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 1997, 19 (04) :313-318

[7] NAIL AND SKIN HYPERPIGMENTATION ASSOCIATED WITH HYDROXYUREA THERAPY FOR POLYCYTHEMIA-VERA [J].

GROPPER, CA ;

DON, PC ;

SADJADI, MM .

INTERNATIONAL JOURNAL OF DERMATOLOGY, 1993, 32 (10) :731-733

[8] SKIN CHANGES SECONDARY TO HYDROXYUREA THERAPY [J].

KENNEDY, BJ ;

SMITH, LR ;

GOLTZ, RW .

ARCHIVES OF DERMATOLOGY, 1975, 111 (02) :183-187

[9]

Kinney TR, 1999, BLOOD, V94, P1550

[10] Hydroxyurea-induced nail pigmentation [J].

Kwong, YL .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1996, 35 (02) :275-276

← 1 2 →